Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathilde Sibony

Showing results (81-90 of 119) with videos related to

Pageof 12
Sort By:
American Journal of Medical Genetics. Part A|April 23, 2015
Refining the regulatory region upstream of SOX9 associated with 46,XX testicular disorders of Sex Development (DSD)Capucine Hyon, Sandra Chantot-Bastaraud, Radu Harbuz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2007
Phenol sulfotransferase SULT1A1*2 allele and enhanced risk of upper urinary tract urothelial cell carcinomaMorgan Rouprêt, Géraldine Cancel-Tassin, Eva Comperat, et al.
Endocrine Connections|July 23, 2020
Intratumor heterogeneity of prognostic DNA-based molecular markers in adrenocortical carcinomaAnne Jouinot, Juliane Lippert, Martin Fassnacht, et al.
Endocrine-Related Cancer|December 8, 2017
Detection and monitoring of circulating tumor DNA in adrenocortical carcinomaSimon Garinet, Juliette Nectoux, Mario Neou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2014
MET is a potential target across all papillary renal cell carcinomas: result from a large molecular study of pRCC with CGH array and matching gene expression arrayLaurence Albiges, Justine Guegan, Audrey Le Formal, et al.
Clinical Nuclear Medicine|February 9, 2023
Positive Correlation Between 18 F-FDG Uptake and Tumor-Proliferating Antigen Ki-67 Expression in Adrenocortical CarcinomasRossella Libé, Aurore Pais, Florian Violon, et al.
Cancer Immunology Research|October 23, 2021
CAR T-cell Entry into Tumor Islets Is a Two-Step Process Dependent on IFNγ and ICAM-1Chahrazade Kantari-Mimoun, Sarah Barrin, Lene Vimeux, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 10, 2020
MET alterations in biphasic squamoid alveolar papillary renal cell carcinomas and clinicopathological featuresThomas Denize, Pierre Alexandre Just, Mathilde Sibony, et al.
Cancer Research|November 23, 2016
Tim-3 Expression on Tumor-Infiltrating PD-1<sup>+</sup>CD8<sup>+</sup> T Cells Correlates with Poor Clinical Outcome in Renal Cell CarcinomaClémence Granier, Charles Dariane, Pierre Combe, et al.
The Journal of Pathology|March 17, 2012
CDKN2A homozygous deletion is associated with muscle invasion in FGFR3-mutated urothelial bladder carcinomaSandra Rebouissou, Aurélie Hérault, Eric Letouzé, et al.
Pageof 12

Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
American Journal of Medical Genetics. Part A|April 23, 2015
Refining the regulatory region upstream of SOX9 associated with 46,XX testicular disorders of Sex Development (DSD)Capucine Hyon, Sandra Chantot-Bastaraud, Radu Harbuz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2007
Phenol sulfotransferase SULT1A1*2 allele and enhanced risk of upper urinary tract urothelial cell carcinomaMorgan Rouprêt, Géraldine Cancel-Tassin, Eva Comperat, et al.
Endocrine Connections|July 23, 2020
Intratumor heterogeneity of prognostic DNA-based molecular markers in adrenocortical carcinomaAnne Jouinot, Juliane Lippert, Martin Fassnacht, et al.
Endocrine-Related Cancer|December 8, 2017
Detection and monitoring of circulating tumor DNA in adrenocortical carcinomaSimon Garinet, Juliette Nectoux, Mario Neou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2014
MET is a potential target across all papillary renal cell carcinomas: result from a large molecular study of pRCC with CGH array and matching gene expression arrayLaurence Albiges, Justine Guegan, Audrey Le Formal, et al.
Clinical Nuclear Medicine|February 9, 2023
Positive Correlation Between 18 F-FDG Uptake and Tumor-Proliferating Antigen Ki-67 Expression in Adrenocortical CarcinomasRossella Libé, Aurore Pais, Florian Violon, et al.
Cancer Immunology Research|October 23, 2021
CAR T-cell Entry into Tumor Islets Is a Two-Step Process Dependent on IFNγ and ICAM-1Chahrazade Kantari-Mimoun, Sarah Barrin, Lene Vimeux, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 10, 2020
MET alterations in biphasic squamoid alveolar papillary renal cell carcinomas and clinicopathological featuresThomas Denize, Pierre Alexandre Just, Mathilde Sibony, et al.
Cancer Research|November 23, 2016
Tim-3 Expression on Tumor-Infiltrating PD-1<sup>+</sup>CD8<sup>+</sup> T Cells Correlates with Poor Clinical Outcome in Renal Cell CarcinomaClémence Granier, Charles Dariane, Pierre Combe, et al.
The Journal of Pathology|March 17, 2012
CDKN2A homozygous deletion is associated with muscle invasion in FGFR3-mutated urothelial bladder carcinomaSandra Rebouissou, Aurélie Hérault, Eric Letouzé, et al.
Pageof 12